Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder

Tomasz (Tom) Beer, Derek Raghavan

    Research output: Contribution to journalArticle

    24 Citations (Scopus)
    Original languageEnglish (US)
    Pages (from-to)184-193
    Number of pages10
    JournalProstate
    Volume45
    Issue number2
    DOIs
    StatePublished - 2000

    Fingerprint

    Cultured Tumor Cells
    Beauty
    Cytotoxins
    Antineoplastic Agents
    Prostatic Neoplasms
    Outcome Assessment (Health Care)
    Clinical Trials
    Hormones
    Drug Therapy

    ASJC Scopus subject areas

    • Urology

    Cite this

    Chemotherapy for hormone-refractory prostate cancer : Beauty is in the eye of the beholder. / Beer, Tomasz (Tom); Raghavan, Derek.

    In: Prostate, Vol. 45, No. 2, 2000, p. 184-193.

    Research output: Contribution to journalArticle

    @article{0b100c462b74486fbd8c2b76944e5a86,
    title = "Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder",
    author = "Beer, {Tomasz (Tom)} and Derek Raghavan",
    year = "2000",
    doi = "10.1002/1097-0045(20001001)45:2<184::AID-PROS13>3.0.CO;2-K",
    language = "English (US)",
    volume = "45",
    pages = "184--193",
    journal = "Prostate",
    issn = "0270-4137",
    publisher = "Wiley-Liss Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Chemotherapy for hormone-refractory prostate cancer

    T2 - Beauty is in the eye of the beholder

    AU - Beer, Tomasz (Tom)

    AU - Raghavan, Derek

    PY - 2000

    Y1 - 2000

    UR - http://www.scopus.com/inward/record.url?scp=0033819784&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0033819784&partnerID=8YFLogxK

    U2 - 10.1002/1097-0045(20001001)45:2<184::AID-PROS13>3.0.CO;2-K

    DO - 10.1002/1097-0045(20001001)45:2<184::AID-PROS13>3.0.CO;2-K

    M3 - Article

    C2 - 11027418

    AN - SCOPUS:0033819784

    VL - 45

    SP - 184

    EP - 193

    JO - Prostate

    JF - Prostate

    SN - 0270-4137

    IS - 2

    ER -